FDA Centralization Plan Under Review; HHS Aiming For “One Clear Message”
This article was originally published in The Gray Sheet
Executive Summary
Consolidation of HHS public affairs and legislative activities across the department will blunt the political impact of the incoming FDA commissioner, potentially allowing the position to focus on science policy and product review issues
You may also be interested in...
FDA Expects To Hire Chief Of Shared Services By July
FDA is targeting early July for selection of a candidate to oversee the agency's new Office of Shared Services, which is slated to begin operations by Oct. 1
FDA Expects To Hire Chief Of Shared Services By July
FDA is targeting early July for selection of a candidate to oversee the agency's new Office of Shared Services, which is slated to begin operations by Oct. 1
Industry, Rep. Buyer Urge Appropriators To Meet User Fee Funding Goals
Congress may reexamine the amount of funds allocated to the device user fee program in the omnibus FY 2003 spending bill, following the Feb. 3 release of President Bush's FY 2004 budget request, which designates only $1 mil. for premarket review activities at CDRH